News

Kojamo plc Surges in Financial Performance in Mid-2025 Review

Kojamo plc Surges in Financial Performance in Mid-2025 Review

Kojamo plc Exhibiting Robust Financial Growth

Kojamo plc has released its Half-Year Financial Report for the period from January to June 2025, underscoring a robust growth trajectory amidst evolving market conditions.

Continued Upsurge in Occupancy Rates

During the first half of 2025, Kojamo witnessed a notable improvement in its occupancy rates, which indicates the company’s ongoing efforts to enhance its residential offerings. The financial occupancy rate rose to 93.6%, compared to 91.7% in the previous year, showcasing the unwavering demand for quality rental properties.

Financial Highlights for April to June 2025

The second quarter figures reflected a steady increase in total revenue, which escalated by 2.9% to reach EUR 115.6 million. Notably, the net rental income climbed 0.9%, amounting to EUR 82.8 million, demonstrating resilience in revenue generation despite industry pressures. The net rental income formed 71.7% of the total revenue for this timeframe.

Key Financial Metrics from Q2 2025

  • Result before taxes posted at EUR -12.7 million, a significant improvement over the corresponding period last year of EUR -104.3 million.
  • Funds From Operations (FFO) also noted a decrease, totaling EUR 38.8 million, declining by 9.3% year-on-year.
  • The gross investments during this quarter came to EUR 10.1 million, which accounted for 8.8% of total revenue.

Six-Month Financial Overview for 2025

Reflecting on the first half of 2025, the total revenue increased by 1.9% to EUR 229.9 million. The net rental income climbed 2.0% to EUR 145.6 million, and it comprised the entirety of 63.3% of total revenue. Despite these gains, the result before taxes was EUR -23.8 million, which included substantial impacts from property valuations.

Investment Properties and Future Prospects

The fair value of Kojamo’s investment properties stood at EUR 7.9 billion at the close of the review period, inclusive of EUR 272.8 million in properties held for sale. Furthermore, the company is engaged in the construction of 119 Lumo apartments to cater to growing housing needs.

Currently, there are 40,946 rental apartments owned by Kojamo, slightly fewer than the previous year, which highlights the company’s strategic pruning of its portfolio to optimize performance and focus on valuable assets.

Outlook for 2025

Kojamo has revised its outlook for 2025, estimating total revenue growth of 0-2%, and projecting the Group’s FFO to reach between EUR 135-141 million, excluding non-recurring costs. This outlook takes into consideration the ongoing developments in property management and customer demand.

CEO Insights on Company Direction

CEO Reima Rytsölä expressed optimism regarding the company’s growth and strategic direction. He noted the improvements in occupancy rates and the effectiveness of customer experience initiatives, which have led to a heightened Net Promoter Score (NPS) of 58.

Additionally, the successful sale of 1,944 apartments in June reflects Kojamo’s strategic focus on strengthening its core portfolio in Finland’s growth centres. This transaction signals a commitment to reducing debt and enhancing shareholder value which is integral to the company’s long-term strategy.

Moreover, Kojamo’s financial position remains healthy with strategic refinancing activities for its bank loans, enhancing liquidity and reducing interest expenses, further solidifying the company's pathway towards sustainable growth.

Looking ahead, the company is poised to navigate the rental market challenges by continuing to focus on customer satisfaction and maintaining a robust portfolio that aligns with its growth vision. With a focus on innovative solutions, Kojamo aims to cater to urban housing needs effectively.

Frequently Asked Questions

What is the current financial occupancy rate for Kojamo?

The financial occupancy rate for Kojamo in the first half of 2025 is 93.6%.

How much did Kojamo’s total revenue grow in Q2 2025?

Kojamo’s total revenue in Q2 2025 grew by 2.9%, reaching EUR 115.6 million.

What are the projected funds from operations (FFO) for 2025?

Kojamo projects that the Group’s FFO for 2025 will range between EUR 135–141 million, excluding non-recurring costs.

How many rental apartments does Kojamo currently own?

Kojamo currently owns 40,946 rental apartments as of mid-2025.

What strategic actions is Kojamo taking to improve its market position?

Kojamo is actively focusing on improving customer experience, refinancing loans, and strategically selling properties not aligned with its core growth objectives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 2

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading

Top 5 Most Recently Viewed Articles

PMGC Capital's Strategic Investment in Alaunos Therapeutics

Updated Category News Views 171

PMGC Capital LLC Plans to File Schedule 13D on Alaunos PMGC Capital LLC, a fully owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), has made a significant move in the financial landscape by announcing its intention to file a Schedule 13D with the U.S. Securities and Exchange Commission (SEC). This filing will disclose its beneficial ownership in Alaunos Therapeutics,...

Continue Reading
Black Diamond Therapeutics: Pivotal Developments Ahead

Updated Category News Views 97

Black Diamond Therapeutics Continues to Make Strides Recently, H.C. Wainwright confirmed a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX) shares, projecting a price target of $11.00. This positive outlook follows the company's major restructuring efforts aimed at advancing BDTX-1535, its leading drug candidate, into pivotal trials. This move is expected to not...

Continue Reading
Eureka Acquisition Corp Announces New Meeting Date and Deadlines

Updated Category News Views 187

Eureka Acquisition Corp's Important Announcement New York — Eureka Acquisition Corp (NASDAQ: EURK), a special purpose acquisition company, has recently made significant announcements regarding the schedule of its extraordinary general meeting. Originally set for June 20, it will now take place on June 25, providing shareholders with extra time for participation. Details...

Continue Reading
Diamedica Therapeutics Hits New Heights with $6.41 Stock Value

Updated Category News Views 118

Diamedica Therapeutics Inc. Achieves 52-Week High Diamedica Therapeutics Inc. (NASDAQ: DMAC) is making headlines as its stock has recently hit a remarkable 52-week high of $6.41. This impressive milestone comes amid a significant growth phase for the company, which is currently valued at around $230 million. The steep rise in the stock price over the past year indicates a...

Continue Reading
J.P. Morgan's Projections for 2025: Capital Market Insights

Updated Category News Views 6083

J.P. Morgan's Capital Market Assumptions for 2025 J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and...

Continue Reading